Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle?

World J Urol. 2013 Jun;31(3):541-6. doi: 10.1007/s00345-012-0849-6. Epub 2012 Mar 4.

Abstract

Purpose: Ureteral stents are frequently associated with side effects. Most patients suffer from storage lower urinary tract symptoms (LUTS). Storage LUTS are commonly attributed to the irritation of the trigone, smooth muscle spasm or a combination of factors. The relationship between microbial ureteral stent colonization (MUSC) and de novo or worsening storage LUTS has not been investigated yet.

Methods: Five hundred ninety-one polyurethane ureteral stents from 275 male and 153 female patients were prospectively evaluated. The removed stents were sonicated to dislodge adherent microorganisms. Urine flow cytometry was performed to detect pyuria. A standardized urinary symptom questionnaire was given to all patients.

Results: Thirty-five per cent of male and 28% of female cases showed de novo or worsened storage LUTS. MUSC was more common in patients with storage LUTS compared to patients without storage LUTS (men: 26 vs. 13%, respectively, P < 0.05; women: 63 vs. 48%, respectively, P = 0.13). Pyuria was significantly more common in patients with storage LUTS compared to patients without storage LUTS (men: 55 vs. 40%, respectively, P < 0.05; women: 70 vs. 45%, respectively, P < 0.05). No significant correlation was observed between the detected genera of microorganisms and storage LUTS.

Conclusions: Our data show a significant association between MUSC- and stent-related de novo experienced or worsened storage LUTS in men. The incidence of MUSC is most common in both female and male patients with storage LUTS and accompanying pyuria. In these patients, a combination of antibiotics and anti-inflammatory drugs may be regarded as treatment option.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Colony Count, Microbial
  • Enterobacteriaceae / isolation & purification*
  • Enterococcus / isolation & purification*
  • Female
  • Humans
  • Incidence
  • Lower Urinary Tract Symptoms / drug therapy
  • Lower Urinary Tract Symptoms / epidemiology*
  • Lower Urinary Tract Symptoms / microbiology*
  • Male
  • Middle Aged
  • Prospective Studies
  • Pyuria / drug therapy
  • Pyuria / epidemiology*
  • Pyuria / microbiology*
  • Retrospective Studies
  • Sex Factors
  • Staphylococcus / isolation & purification*
  • Surveys and Questionnaires
  • Treatment Outcome
  • Urinary Catheters / adverse effects
  • Urinary Catheters / microbiology*

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents